SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-017331
Filing Date
2024-04-02
Accepted
2024-04-02 17:16:12
Documents
14
Period of Report
2024-04-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20025617_8k.htm   iXBRL 8-K 34561
2 EXHIBIT 10.1 ef20025617_ex10-1.htm EX-10.1 100916
  Complete submission text file 0001140361-24-017331.txt   299008

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA adma-20240401.xsd EX-101.SCH 3880
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20240401_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20240401_pre.xml EX-101.PRE 16054
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20025617_8k_htm.xml XML 4059
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 24815557
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)